Table 3.
Adolescent Participants | |||
---|---|---|---|
Spark (N = 35) | Active Control (N = 25) | Test Statistic | |
Age, M (SD) | 17.91 (2.36) | 16.96 (2.57) | t(58) = 2.00, p = .14 |
Gender, N (%) | χ2 (2) = .93, p = .62 | ||
Male | 6 (17.14%) | 5 (20.00%) | |
Female | 28 (80.00%) | 19 (76.00%) | |
Non-binary | 1 (2.86%) | 1 (4.00%) | |
Race, N (%) | χ2 (5) = .59, p = .99 | ||
American Indian/Alaska Native | 1 (2.86%) | 0 (0.00%) | |
Asian | 7 (20.00%) | 4 (16.00%) | |
Black or African American | 2 (5.71%) | 3 (12.00%) | |
Native Hawaiian or Other Pacific Islander | 0 (0.00%) | 0 (0.00%) | |
Unknown | 2 (5.71%) | 0 (0.00%) | |
White | 20 (57.14%) | 17 (68.00%) | |
Mixed Race | 3 (8.57%) | 1 (4.00%) | |
Ethnicity, N (%) | χ2 (1) = .91, p = .34 | ||
Hispanic/Latino | 6 (17.14%) | 4 (16.00%) | |
Not Hispanic/Latino | 29 (82.85%) | 21 (84.00%) | |
Baseline PHQ-8, M (SD) | 13.74 (6.02) | 13.92 (5.32) | t(58) = 2.00, p = .90 |
Severity, N (%) | χ2 (1) = .86, p = .35 | ||
mild-moderate (up to 15) | 23 (65.71%) | 16 (64.00%) | |
moderate to severe (above 15) | 12 (34.29%) | 9 (36.00%) | |
Depression Diagnosis, N (%) | 18 (51.43%) | 14 (56.00%) | χ2 (1) = .73, p = .39 |
Concurrent treatment for depression, N (%) | χ2 (5) = .57, p = .99 | ||
Medication only | 5 (14.29%) | 8 (32.00%) | |
None | 19 (54.29%) | 12 (48.00%) | |
Other | 1 (2.86%) | 0 (0.00%) | |
Psychotherapy only | 4 (11.43%) | 2 (8.00%) | |
Medication and Psychotherapy | 5 (14.28%) | 3 (12.00%) | |
Unknown | 1 (2.86%) | 0 (0.00%) | |
Legal Guardians | |||
Spark (N = 16) | Active Control (N = 13) | ||
Education Level, N (%) | χ2 (5) = .50, p = 0.99 | ||
Middle school | 3 (18.75%) | 1 (7.69%) | |
High school/GED | 1 (6.25%) | 0 (0.00%) | |
Some college | 1 (6.25%) | 3 (23.07%) | |
Associate's and/or Bachelor's degree | 9 (56.25%) | 6 (46.15%) | |
Master's degree | 2 (12.50%) | 2 (15.38%) | |
Doctoral or Professional degree | 0 (0.00%) | 1 (7.69%) |